Prevalence of cognitive impairment in patients with substance use disorder

Abstract Introduction and Aims Cognitive impairments in substance use disorder predict treatment outcome and are assumed to differ between substances. They often go undetected, thus the current study focuses on the prevalence of and differences in cognitive functioning across substances by means of a cognitive screen at the early stage of addiction treatment. Design and Methods The Montreal Cognitive Assessment was administered to outpatients seeking treatment for substance use disorder. Patient characteristics (age, years of regular use, polysubstance use, severity of dependence/abuse, depression, anxiety and stress) were also taken into account. Results A total of 656 patients were included (n = 391 used alcohol, n = 123 used cannabis, n = 100 used stimulants and n = 26 used opioids). The prevalence of cognitive impairments was 31%. Patients using alcohol had a lower total‐ and memory domain score than those using cannabis. Patients using opioids scored lower on visuospatial abilities than those using cannabis or stimulants. Younger patients scored higher than older patients. No effect was found for the other investigated characteristics. Discussion and Conclusions Given the high prevalence of cognitive impairments, standard screening at an early stage of treatment is important to determine the course of treatment and maximise treatment outcome. Caution is needed in interpreting results about opioids due to an underrepresentation of this patient group, and more research is needed on the effect of age on Montreal Cognitive Assessment performance.

• Publication year

  2019

• Venue

  Drug and Alcohol Review

• Publication date

  2019-03-27

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/dar.12922PMID 30916448PMCID 6593747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Errorless (re)learning of everyday activities in patients with Korsakoff’s syndrome: A feasibility study

  2019cited by this paper
• Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.

  2019cited by this paper
• The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice

  2018influential reference
• Assessment of neurocognitive disorder in studies of cognitive impairment due to substance use disorder: A systematic review

  2018cited by this paper
• Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of Longitudinal Studies

  2017cited by this paper
• Korsakoff’s syndrome: a critical review

  2017cited by this paper
• The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.

  2016cited by this paper
• Chronic stimulant use: An upcoming cause of neurocognitive disorder in later life?

  2016cited by this paper
• MoCA as a Screening Tool of Neuropsychological Deficits in Alcohol-Dependent Patients.

  2015cited by this paper
• Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study

  2014cited by this paper
• Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation

  2014cited by this paper
• Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment.

  2014cited by this paper
• Characterizing the cognitive effects of cocaine: a comprehensive review.

  2013cited by this paper
• [The neuropsychology of cognitive functions in alcohol abstinence].

  2013cited by this paper
• Widespread and sustained cognitive deficits in alcoholism: a meta‐analysis

  2013cited by this paper
• Neuropsychologische diagnostiek en cognitieve functies bij alcoholabstinentie [The neuropsychology of cognitive functions in alcohol abstinence]

  2013cited by this paper
• Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review.

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Montreal Cognitive Assessment: influence of sociodemographic and health variables.

  2012cited by this paper
• Neurocognitive parameters should be incorporated in the Minnesota Multiphasic Personality Inventory-2 assessment of patients with alcohol use disorders.

  2012cited by this paper
• What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance?

  2011cited by this paper
• Drug-related decrease in neuropsychological functions of abstinent drug users.

  2011influential reference
• P1‐144: Integration of cognitive impairments and white matter hyperintensities into a 12‐cell diagnostic matrix system: Analysis of 3,966 subjects from the CREDOS study

  2011cited by this paper
• An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions

  2011cited by this paper
• The association between executive functioning and motivation to enter treatment among regular users of heroin and/or cocaine in Baltimore, MD.

  2010cited by this paper
• Effects of acute alcohol consumption on executive cognitive functioning in naturalistic settings.

  2010cited by this paper
• Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence

  2010cited by this paper
• The Neuropsychology of Cocaine Addiction: Recent Cocaine Use Masks Impairment

  2009cited by this paper
• Changes in the episodic memory and executive functions of abstinent and relapsed alcoholics over a 6-month period.

  2009cited by this paper
• Rapid cognitive screening of patients with substance use disorders.

  2009cited by this paper
• Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention.

  2007cited by this paper
• Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis

  2007cited by this paper
• Neuropsychological Consequences of Opiate Use

  2007cited by this paper
• Cognitive deficits predict low treatment retention in cocaine dependent patients.

  2006cited by this paper
• Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Neurocognitive Deficits in Cocaine Users: A Quantitative Review of the Evidence

  2005cited by this paper
• Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.

  2005cited by this paper
• Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex.

  2004cited by this paper
• Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment.

  2003cited by this paper
• Cognitive functioning of long-term heavy cannabis users seeking treatment.

  2002cited by this paper
• Neuropsychological deficits and opiate abuse.

  2002cited by this paper
• Substance abuse treatment outcomes for cognitively impaired and intact outpatients

  2002cited by this paper
• Neuropsychological performance in long-term cannabis users.

  2001cited by this paper
• Substance abuse treatment outcomes for cognitively impaired and intact outpatients.

  1999cited by this paper
• The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.

  1995influential reference
• Experience-dependent neuropsychological recovery and the treatment of alcoholism.

  1993cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• Is there more than one neuropsychological disorder commonly associated with alcohol dependence?

  1992cited by this paper
• Acute alcohol intoxication and cognitive functioning.

  1990cited by this paper
• Experience-dependent recovery of cognitive deficits in alcoholics: extended transfer of training.

  1987cited by this paper

• The influence of virtual clinics on perceptions of stigma, appointment compliance among patients with mental illness and substance use disorder: Findings from the cross-sectional design.

  2026cites this paper
• The relationship between metacognitive beliefs and healthy aging among older adults.

  2026cites this paper
• A multicenter study to validate the Brief Cognitive Status Examination as a screening tool for the detection of cognitive impairment in a substance use disorder population over 45 years of age in a Spanish population.

  2026cites this paper
• Improving social cognition in individuals with substance use disorders through the E-motional training program: A pilot study.

  2026cites this paper
• Neuropsychological impairment detected by the Montreal Cognitive Assessment monitors recovery and predicts treatment dropout in substance use disorders

  2026cites this paper
• Alpha-2 Adrenergic Agonists Reduce Heavy Alcohol Drinking and Improve Cognitive Performance in Mice

  2026cites this paper
• Evaluation of self-control, psychological resilience and addiction severity levels of individuals diagnosed with substance use disorder

  2025cites this paper
• Characterization of cognitive impairment and contributing factors in patients with substance use disorders: Influence of primary alcohol or cocaine use.

  2025cites this paper
• Neuroanatomical features reveal accelerated brain age in alcohol use disorder

  2025cites this paper
• Feasibility of a Cognitive-Behavioral-Therapy-Based Addiction Intervention for Relapse Prevention for Patients with Alcohol-Related Cognitive Impairments: A Controlled Pilot Study

  2025cites this paper
• Prevalence of cognitive impairment in Moroccan patients with substance use disorder

  2025cites this paper
• Integrative cognitive neuropsychological program emphasizing brain response to enhance inhibitory control among substance abusers at the alternative rehabilitation communities in Eastern Thailand

  2025cites this paper
• The relationship between subjective sleep disturbances and illness insight in individuals with alcohol‐related cognitive disorders

  2025cites this paper
• Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker

  2025cites this paper
• An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction

  2025cites this paper
• Examining the Triad of Personality, Cognition, and Quality of Life in Alcohol and Opioid Consumers

  2025cites this paper
• The Burden and Determinants of Cognitive Impairment Among Individuals with Chronic Diseases in Ethiopia: A Systematic Review and Meta-Analysis

  2025cites this paper
• The Effect of Self-Compassion-Focused Interventions for People with Substance Use Disorders: A Systematic Review and Meta-Analysis

  2025cites this paper
• Impaired insight in concurrent disorders: identifying patterns in drug seeking behaviours

  2025cites this paper
• Neurocognitive Functions Among Patients Dependent on Natural Opium: A Comparative Cross-Sectional Study

  2025cites this paper
• Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program

  2025cites this paper
• Development and usability of VRainSUD’s cognitive training virtual reality platform for substance use disorders

  2025cites this paper
• Primer Consenso Argentino sobre el manejo del Trastorno por Déficit de Atención e Hiperactividad en la adultez. Segunda parte: clínica del TDAH en la adultez, evaluación diagnostica, comorbilidades y diagnósticos diferenciales

  2025cites this paper
• Die Alkoholdemenz

  2025cites this paper
• Brain Fog and Cognitive Dysfunction in Posttraumatic Stress Disorder: An Evidence-Based Review

  2025cites this paper
• The repeatable battery for the assessment of neuropsychological status (RBANS) and substance use disorders: a systematic review

  2025cites this paper
• Neuroprotective Effect of Rutin on Neurobehavioral Dysfunction and Cognitive Impairment-Induced by Methamphetamine in Male Rats

  2025cites this paper
• Embodied Cognition and Alcohol Use Disorder: Frequency of Impairments and Relationship to Neurocognitive Assessments

  2025influential citation
• Cognitive function among methadone assisted treatment patient in Malaysia.

  2025cites this paper
• Cognitive Function among People with Severe Substance Use

  2025influential citation
• Cognitive impairment in alcohol use disorder and clinical practice guidelines for management of long-stay alcohol use disorder patients

  2025cites this paper
• Navigating Risk: A Comprehensive Study on Pedestrian-Vehicle Collision Factors.

  2025cites this paper
• Utilizing multimodal cortical parcellations to identify novel regions of the human cerebral cortex associated with substance use disorders.

  2025cites this paper
• Impact of psychoactive substances and attention-related impairments on driving performance: Sex differences and road crash involvement.

  2025cites this paper
• Why clinical neuropsychology matters in schizophrenia care

  2025cites this paper
• Assessment of cognitive functions in patients with alcohol dependence disorder and its implications for primary care: A cross-sectional study

  2025cites this paper
• Self-Reported Cognitive Impairments in Office-Based Treatment for Opioid Use Disorder with Buprenorphine or Extended-Release Naltrexone

  2025cites this paper
• Managing Dual Diagnosis Patients and the Importance of Assessing Capacity: Data from London Inpatient Services

  2025cites this paper
• Role of Executive Functions in Substance Use Disorder

  2025cites this paper
• Cannabis and Cognition in Schizophrenia: Systematic Review of Research Published from 2011 To 2024

  2025cites this paper
• Pain and Cognitive Concerns Among Breast Cancer Survivors: The Mediating Role of Substance Use Coping

  2025cites this paper
• Treating Substance Use Disorder in Individuals With Intellectual Disability: A Regional System Capacity Assessment.

  2025cites this paper
• Addiction as disability: disparities in accessing SSDI benefits for substance use disorders

  2025cites this paper
• Experiences and barriers to alcohol use disorder treatment among adults with and without self‐reported executive functioning challenges: A mixed‐methods study

  2025cites this paper
• Subjective and objective assessments of executive functions are independently predictive of aggressive tendencies in patients with substance use disorder.

  2024cites this paper
• Default mode network aberrance in subjects of alcohol and opioid use disorders during working memory task: An exploratory EEG microstates study

  2024cites this paper
• Substance use problems and disorders among adults 50 years and older receiving mental health treatment for a primary neurocognitive disorder

  2024cites this paper
• Assessment of memory deficits in psychiatric disorders: A systematic literature review

  2024cites this paper
• Cognitive training interventions for substance use disorders: what they really offer?

  2024cites this paper
• Social and cognitive determinants of medications for opioid use disorder outcomes: A systematic review using a social determinants of health framework

  2024cites this paper
• The NRF2 activator RTA-408 ameliorates chronic alcohol exposure-induced cognitive impairment and NLRP3 inflammasome activation by modulating impaired mitophagy initiation.

  2024cites this paper
• Validity of the brief executive-function assessment tool in an outpatient substance use disorder setting

  2024influential citation
• How Financial Beliefs and Behaviors Influence the Financial Health of Individuals Struggling with Opioid Use Disorder

  2024cites this paper
• 20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes

  2024cites this paper
• The test-retest reliability of the Opiate Treatment Index in nyaope users in Johannesburg

  2024cites this paper
• Measuring Episodic Verbal Learning Ability in Alcohol-Related Cognitive Disorders in Relation to Everyday Functioning

  2024cites this paper
• Conduites addictives chez la personne âgée

  2024cites this paper
• Leveraging Online Treatment to Re-examine the Association Between Alcohol Use and Disinhibition.

  2024cites this paper
• Assessment of Cognitive Function in Romanian Patients with Chronic Alcohol Consumption

  2024cites this paper
• Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV

  2024cites this paper
• Testing the feasibility, acceptability, and preliminary efficacy of integrating accommodation strategies into an HIV prevention intervention for people who inject drugs with cognitive dysfunction.

  2024cites this paper
• The family and substance abuser in the mental health institution environment

  2024cites this paper
• Cognitive Impairment as A Vulnerability for Exploitation: A Scoping Review

  2024cites this paper
• Objective and subjective measurement of sleep in people who use substances: Emerging evidence and recommendations from a systematic review

  2024cites this paper
• Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction

  2024cites this paper
• Can high-intensity interval training improve health outcomes among people with substance use disorders? A systematic review and preliminary meta-analysis

  2024cites this paper
• New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review

  2024cites this paper
• Is Transcranial Direct Current Stimulation Effective for Cognitive Dysfunction in Substance Use Disorders? A Systematic Review

  2024cites this paper
• Cognitive Impairments and Its Related Factors in People Who Injects Drugs in Iran

  2024cites this paper
• Neurocognitive and clinical profile of male patients with substance use disorder in early remission phase with and without comorbid depression.

  2024cites this paper
• A Little “Re-Cognition” Goes a Long Way for Pro-Cognitive Therapeutics in Alcohol Studies

  2024cites this paper
• Evaluation of metacognition, difficulties in emotion regulation and addiction severity levels of individuals diagnosed with substance use disorder

  2024influential citation
• Prediction of brain age in individuals with and at risk for alcohol use disorder using brain morphological features

  2024cites this paper
• Exploring user experiences of a text message-delivered intervention among individuals on opioid use disorder treatment in Kenya: A qualitative study

  2023cites this paper
• Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

  2023cites this paper
• Effects of neuromodulation on cognitive and emotional responses to psychosocial stressors in healthy humans

  2023cites this paper
• Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

  2023cites this paper
• Performance of dialysis patients on the standard and basic Arabic versions of the Montreal Cognitive Assessments

  2023cites this paper
• Differential Effects of Chronic Ethanol Use on Mouse Neuronal and Astroglial Metabolic Activity

  2023cites this paper
• Perfect sense: The case for sensationalising telephone interventions for people with alcohol and other drug issues.

  2023cites this paper
• Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study

  2023cites this paper
• Questionable utility of the Montreal Cognitive Assessment (MoCA) in detecting cognitive impairment in individuals with comorbid PTSD and SUD

  2023cites this paper
• Relación entre la cantidad y el tipo de alcohol (destilado versus fermentado) consumido y el riesgo de aparición de deterioro cognitivo compatible con un síndrome demencial en personas mayores de 60 años: revisión sistemática

  2023cites this paper
• Cognitive impairment in opioid use disorders: Is there a case for use of nootropics?

  2023cites this paper
• Cognitive Alterations in Addictive Disorders: A Translational Approach

  2023cites this paper
• Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population

  2023cites this paper
• Effects of adenosine A2A receptors on cognitive function in health and disease.

  2023cites this paper
• Assessment of cognitive functioning using the Mini Mental State Examination in men with alcohol and crack cocaine use disorder

  2023cites this paper
• Toward Cognition-Aware Digital Phenotyping for Substance Use Disorder

  2023influential citation
• Impaired Executive Functioning Associated with Alcohol-Related Neurocognitive Disorder including Korsakoff’s Syndrome

  2023cites this paper
• Five Challenges in Implementing Cognitive Remediation for Patients with Substance Use Disorders in Clinical Settings

  2023cites this paper
• Effect of alcohol-dependence on cognitive performance in middle-aged men: Preliminary results

  2023cites this paper
• Systematic Review and Meta-Synthesis of Research Studies Related to Factors Affecting Substance Use in Iran from 2002 to 2021

  2023cites this paper
• Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?

  2022cites this paper
• Screening Executive Functions in Substance-Use Disorder: First Evidence from Testing of the Battery for Executive Functions in Addiction (BFE-A)

  2022influential citation
• The Use of Smartphone Serious Gaming Apps in the Treatment of Substance Use Disorders: Observational Study on Feasibility and Acceptability

  2022cites this paper
• Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

  2022cites this paper
• Comparison between Screening Cognitive Impairment in Psychiatry (SCIP-S) and Minimental State Examination (MMSE) in Forensic Psychiatry. Pilot study

  2022cites this paper
• Effects of comorbid posttraumatic stress disorder on cognitive dysfunction in Chinese male methamphetamine patients.

  2022cites this paper
• Editorial: Polysubstance Abuse and Cognitive Dysfunction

  2022cites this paper